Emma Aarnio
University of Eastern Finland(FI)Finland University(FI)
Publications by Year
Research Areas
Medication Adherence and Compliance, Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Practices and Patient Outcomes, Pharmaceutical Economics and Policy, Peripheral Artery Disease Management
Most-Cited Works
- → Socioeconomic Inequalities in Statin Adherence Under Universal Coverage(2016)46 cited
- → Eight-year trajectories of changes in health-related quality of life in knee osteoarthritis: Data from the Osteoarthritis Initiative (OAI)(2019)34 cited
- → Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes(2020)34 cited
- → Health-related quality of life in relation to symptomatic and radiographic definitions of knee osteoarthritis: data from Osteoarthritis Initiative (OAI) 4-year follow-up study(2018)33 cited
- → Register-based predictors of adherence among new statin users in Finland(2013)31 cited
- → Measurement of statin exposure in the absence of information on prescribed doses(2014)26 cited
- → Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population(2019)26 cited
- → Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence – Estimates from the Finnish prescription register(2015)24 cited
- → Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease(2019)20 cited
- → Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study(2022)17 cited